摘要
欧洲是世界上最大的中草药市场之一,文章通过对我国中药出口欧盟市场现状的量化分析,发现我国中药出口欧盟市场份额小、产品附加值低。对此,论文从欧盟中药注册准入制度的注册范围、注册程序、注册质量标准和出口知识产权保护四个方面对所存在的障碍加以剖析,并给出一些对策建议,以期扩大我国中药在欧盟国家的市场份额。
European Union is one of the largest herbal medicinal products market in the world. Through quantitative analysis on the exportation status of traditional Chinese medicine to the Euro- pean countries, this paper finds that the market share of the products exported was rather limited and the additional value of them was extremely low. This paper takes the study of the barrier in the European admittance system of registration of traditional Chinese medicine as the entry point. Emphasis is mainly put on the discussion of registration ranse, procedures, standard of qualities and protection of intellectual property. At the end of the paper, some suggestions are given in order that the market share of the traditional Chinese medicine exported to the European countries will be enlarged.
基金
国家知识产权局软科学研究项目阶段性成果
项目主持人:丁锦希
项目名称<创新药物研发的知识产权激励和保护政策研究>
项目编号:SS09-A-26
关键词
欧盟
中药注册
障碍
注册范围
注册程序
质量标准
知识产权保护
European Union
Registration of traditional Chinese medicine
Barrier
Registrationrange
Registration procedures
Quality standards
Protection of intellectual property
